Research
Part 4
Debate: What is the most effective strategy for preparticipation screening to detect cardiovascular abnormalities in trained athletes?
Counterpoint: The U.S. Perspective
Barry J. Maron, MD
The Italian ...
Part 3
Mutations do not predict risk for sudden death
Michael J. Ackerman, MD
Research and increased use of genetic testing in HCM has greatly increased ...
Part 2
The spectrum of progressive heart failure in HCM: Clinical-pathologic correlations
Christina Basso, MD, PhD
Pathology is of increasing importance in understanding HCM. Heart transplants have allowed ...
The 4th International Summit on HCM took place October 16-18 2009 at the Hyatt in Minneaplois MN. The HCMA had 4 note takers in the audience and the data below is a combination of the notes taken by Dick Melia, Linda Price, Cynthia Burstein Waldman and Lisa Salberg. These note are not intended to be 100% complete, but should permit the reader an insight to the event, content and subject matter discussed.
Should you have questions about the content please direct them to Lisa Salberg at Lisa@4hcm.org and she will get back to you. ...
The HCMA is happy to provide you the oppurtunity to participate in a number of surveys. The aim of the surveys are varied but the ultimate goal is to better understand HCM, how it impacts families, how to better identify those at risk and to save and improve the lives of those impacted by HCM.
...
Several leading HCM programs are continuing work on genetics within research and other areas that offer promise and hope of better understanding, treating and hopefully ...
Participation in research
Should you wish to participate in a research protocol you should be aware of several factors pre-participation and ask key questions to ...
At present there is no cure for Hypertrophic Cardiomyopathy. In current days we are encouraged at the idea we may be able to eradicate, not ...
